US Stock MarketDetailed Quotes

SRDX SurModics

Watchlist
  • 34.620
  • +0.540+1.58%
Close May 17 16:00 ET
  • 34.620
  • 0.0000.00%
Post 16:01 ET
492.85MMarket Cap36.06P/E (TTM)

About SurModics Company

Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. The firm operates through the following segments: Medical Device, In Vitro Diagnostics, and Corporate. The Medical Device segment designs, develops, and manufactures vascular interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment is composed of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.

Company Profile

SymbolSRDX
Company NameSurModics
Listing DateMar 4, 1998
Issue Price7.50
Founded1979
CEOMr. Gary R. Maharaj
MarketNASDAQ
Employees376
Securities TypeOrdinary Shares
Fiscal Year Ends09-30
Address9924 West 74th Street
CityEden Prairie
ProvinceMinnesota
CountryUnited States of America
Zip Code55344-3523
Phone1-952-500-7000

Company Executives

  • Name
  • Position
  • Salary
  • Gary R. Maharaj
  • Director, President and Chief Executive Officer
  • 3.53M
  • Timothy J. Arens
  • Senior Vice President, Finance and Information Technology and Chief Financial Officer
  • 1.30M
  • John D. Manders
  • Vice President, Finance, Corporate Controller and Principal Accounting Officer
  • --
  • Gordon S. Weber
  • General Counsel, Senior Vice President, Legal and Secretary
  • 1.10M
  • Charles W. Olson
  • Senior Vice President and President, Medical Device Coatings
  • 1.12M
  • Joseph J. Stich
  • Senior Vice President, Human Resources and President, In Vitro Diagnostics
  • --
  • Teryl L.W. Sides
  • Senior Vice President and President, Vascular Interventions
  • 1.49M
  • Susan E. Knight
  • Chairman of the Board
  • 229.00K
  • Jose H. Bedoya
  • Independent Director
  • 176.50K
  • Dr. David R. Dantzker, M.D.
  • Independent Director
  • 185.00K
  • Lisa Wipperman Heine
  • Independent Director
  • 176.50K
  • Ronald B. Kalich, Sr
  • Independent Director
  • 186.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg